Indian Pharma Companies Concerned Over Trump's Proposed Generic Drug Tariffs
Indian pharmaceutical companies are expressing significant concern and uncertainty following former President Donald Trump's proposal to impose tariffs, potentially up to 200%, on generic drug imports. This move could severely impact India's dominant position in the global generic drug market.